Why is GPT Healthcare falling/rising?

As of 21-Aug, GPT Healthcare Ltd is currently priced at 159.50, reflecting a rise of 0.8 or 0.5%. Today's performance indicates that the stock has outperformed its sector by 0.82%. However, it has shown a decline of 0.68% over the past week and a significant drop of 12.75% year-to-date. The stock's moving averages reveal that it is higher than the 100-day moving average but lower than the shorter-term averages, suggesting mixed momentum. Despite a high management efficiency with a return on capital employed (ROCE) of 28.30% and a low debt-to-equity ratio of 0.02, the stock has been underperforming, with a return of -18.87% over the past year. The recent negative quarterly results, including a 38.5% drop in profit after tax, have likely contributed to investor concerns, alongside a decrease in institutional investor participation.
In the broader market context, the Sensex has risen by 1.74% over the past week, contrasting with GPT Healthcare's decline. While the stock has outperformed its sector today, its longer-term performance remains concerning, with a consistent underperformance against the benchmark over the last three years. The stock's negative returns, coupled with falling institutional interest, suggest that while there may be short-term gains, the overall outlook remains cautious as it struggles to keep pace with the broader market trends.